Given the critical role of anti-viral IgA in infection control upon mucosal entry of SARS-CoV-2 variants, the lack of IgA induction potentially renders COVID-19 mRNA vaccines ineffective in blocking virus variant transmission. Here, CD79A is linked to COVID-19.